Evidence map›Paper›PMID 42852211›Full record

ArticleACS omega2026

Interpretable Machine Learning Frameworks for QSAR Modeling: A Comparative Study of Classical Algorithms and Transformer-CNN Architectures.

Fatima Ezzahra Belkhanchi, Mohamed Mbarki, Samir Chtita, Amit Kumar Halder, M Natália D S Cordeiro

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fatima Ezzahra BelkhanchiTeam of Analytical & Computational Chemistry, Nanotechnology and Environment, Faculty of Science and Technologies, Sultan Moulay Slimane University, BP 523 Beni Mellal, Morocco.
Mohamed MbarkiTeam of Analytical & Computational Chemistry, Nanotechnology and Environment, Faculty of Science and Technologies, Sultan Moulay Slimane University, BP 523 Beni Mellal, Morocco.
Samir ChtitaLaboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, B.P 7955 Casablanca, Morocco.
Amit Kumar HalderLAQV@REQUIMTE/Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.
M Natália D S CordeiroLAQV@REQUIMTE/Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.ORCID https://orcid.org/0000-0003-3375-8670

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphodiesterase type 5A (PDE5A) inhibitors represent an important class of bioactive molecules with therapeutic relevance across cardiovascular, neurological, and oncological disorders. In this work, we develop an interpretable Quantitative Structure-Activity Relationship (QSAR) framework that integrates classical machine learning (ML) approaches with a hybrid deep learning architecture (Transformer-Convolutional Neural Network, Transformer-CNN) to model enzyme inhibition using a curated and diverse data set from ChEMBL. Multiple structural descriptors and fingerprint-based representations were evaluated using established ML algorithms, with fingerprint-driven models, particularly those employing FCFP4 features, achieving the highest predictive performance with Matthews Correlation Coefficients up to 0.783. Comparative analysis revealed that optimized classical ML models slightly outperform the Transformer-CNN approach for this data set. Model interpretability was explored through Shapley Additive Explanations (SHAP) analysis, similarity maps, and atom-wise relevance scores, providing mechanistic insights and highlighting the importance of molecular symmetry and topological features in determining inhibitory potency. To support practical deployment, the final models were implemented in a freely accessible web application built with Flask and Streamlit for rapid prediction of novel compounds' inhibitory potential. Overall, this work provides a transparent and reproducible QSAR workflow, clarifies the relative strengths of classical and deep learning approaches, and offers a practical tool to assist in the design of next-generation PDE5A inhibitors.

Identifiers

PMID42852211
PMCPMC13647328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.